berotek and interleukin-8
berotek has been researched along with interleukin-8 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Inagaki, N; Kobayashi, J; Kurita, C; Nagai, H; Nagao, T; Nakao, T; Tanaka, H; Usami, E; Watanabe, S; Yamazaki, F; Yoshimura, T | 1 |
| Farmer, P; Pugin, J | 1 |
| Halayko, AJ; Jansen, E; Maarsingh, H; Menzen, MH; Meurs, H; Oldenburger, A; Roscioni, SS; Schmidt, M; Timens, W | 1 |
Other Studies
3 other study(ies) available for berotek and interleukin-8
| Article | Year |
|---|---|
Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cell Separation; Cells, Cultured; Clenbuterol; Cyclic AMP; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Fenoterol; Humans; Interleukin-1; Interleukin-8; Leukocytes, Mononuclear; Lipopolysaccharides; Procaterol; Propranolol; Terbutaline; Theophylline; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1997 |
beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Bucladesine; Cell Line; Cell Nucleus; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; DNA-Binding Proteins; Enzyme Activation; Epinephrine; Fenoterol; Gene Expression Regulation; Humans; I-kappa B Proteins; Iloprost; Interleukin-8; Isoproterenol; Kinetics; Lipopolysaccharide Receptors; Lipopolysaccharides; Monocytes; NF-kappa B; NF-KappaB Inhibitor alpha; Norepinephrine; Tumor Necrosis Factor-alpha | 2000 |
Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bronchi; Cell Nucleus; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Female; Fenoterol; Gene Knockdown Techniques; Guanine Nucleotide Exchange Factors; Humans; I-kappa B Proteins; Interleukin-8; Male; Middle Aged; Myocytes, Smooth Muscle; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Transport; Pulmonary Disease, Chronic Obstructive; Signal Transduction; Smoking; Transcription Factor RelA | 2012 |